Document is current
Any future updates will be listed below
-
Authors
Djinbachian, Roupen
Lafontaine, Marie-Lyssa
Dufault, Talia
Medawar, Edgard
Boivin, Michel
Bouin, Mickael
von Renteln, Daniel
-
Funding
Funding for this research was provided by:
American College of Gastroenterology
- License Information
-
More Information
Article History
Received: 10 July 2022
Accepted: 21 February 2023
First Online: 21 March 2023
Declarations
:
: Daniel von Renteln is supported by a “Fonds de Recherche du Québec Santé” (FRQS) career development award and has received research funding from ERBE, Ventage, Pendopharm, and Pentax and is a consultant for Boston Scientific and Pendopharm. Daniel von Renteln has no other personal or financial conflicts of interest relevant to this paper to declare. Marie-Lyssa Lafontaine, Talia Dufault, Edgard Medawar, Michel Boivin, Mickael Bouin have no conflicts of interest relevant to this paper to declare.
